Navigating the Planning and Initiation of a First Prospective Clinical Trial Through a Regional Pediatric Oncology Consortium Within the Middle East, Africa, and Asia—A Roadmap
Pediatric Blood & Cancer · 2026-10 · 73 (10)
DOI: 10.1002/1545-5017.70556 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 31.07.2026. Verfasst von Ruzanna Papyan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Pediatric Oncology, Yerevan State Medical University, Yerevan, Armenia. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Osteosarcoma, Bone Neoplasms, Medical Oncology. Die Arbeit nennt 19 Literaturangaben. Gefördert von: Programme for Advancing the Research Capacity, International Society of Paediatric Oncology, American Lebanese Syrian Associated Charities.
Abstract (Originalsprache)
Background
Prospective pediatric oncology clinical trials remain scarce across low‐ and middle‐income countries (LMICs). We developed the first multicountry prospective clinical trial within the Pediatric Oncology East and Mediterranean (POEM) group. Localized osteosarcoma was selected due to heterogeneous real‐world management, including alternative regimens in settings where methotrexate administration is not feasible. This descriptive report details the feasibility of a regionally coordinated, resource‐adapted clinical trial across diverse LMIC settings.
Methods
We describe the planning, capacity assessment, training, governance, and activation of POEM‐OS, a pragmatic two‐arm prospective cohort study evaluating MAP‐ and OS99‐based therapy for localized osteosarcoma. Preparation included a structured capacity‐mapping exercise across regional centers to assess clinical resources, research, and regulatory structures. The approach also encompassed designing a training program and communication through a structured study coordination team.
Results
A total of 27 centers from 10 countries expressed intent to participate. A 12‐week virtual training curriculum was implemented for principal investigator and clinical research coordinator dyads, followed by an in‐person regional workshop. Eventually, 21 centers (8 countries) proceeded to study activation. Major barriers included heterogeneity in chemotherapy administration, high staff turnover, and variability in timelines to study‐agreement execution. Adaptive solutions included permanently accessible online training modules, simplified chemotherapy dosing, and harmonized toxicity grading. Centralized REDCap platforms enabled regional data sharing. By February 2026, the study had opened at 16 centers, with 21 patients enrolled.
Conclusion
POEM‐OS demonstrates that a regionally directed, resource‐adapted clinical trial platform is feasible across diverse LMIC settings and establishes a foundation for sustainable regional clinical research infrastructure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology and Pediatric Oncology, Yerevan State Medical University, Yerevan, Armenia.
- Yeolyan Hematology and Oncology Center, Yerevan, Armenia.
- Immune Oncology Research Institute, Yerevan, Armenia.
- Department of Anatomy, Cell Biology and Physiological Sciences and POEM Central Office, American University of Beirut, Beirut, Lebanon.
- Department of Pediatric Oncology, National Cancer Institute, Cairo University and Children's Cancer Hospital Egypt, Cairo, Egypt.
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
ORCID-Profile: Ruzanna Papyan, Asim Belgaumi, Venkatraman Radhakrishnan, Carlos Rodriguez-Galindo, Sima Jeha, Victor M Santana, Raya Saab
Förderung
- Programme for Advancing the Research Capacity
- International Society of Paediatric Oncology
- American Lebanese Syrian Associated Charities
Zitieren
APA
Papyan, R., Ghamloush, F., Sidhom, I., Belgaumi, A., Nasr, R., Sultan, I., Tamamyan, G., Radhakrishnan, V., Rodriguez-Galindo, C., Jeha, S., Santana, V. M., & Saab, R. (2026). Navigating the Planning and Initiation of a First Prospective Clinical Trial Through a Regional Pediatric Oncology Consortium Within the Middle East, Africa, and Asia—A Roadmap. Pediatric Blood & Cancer, 73(10). https://doi.org/10.1002/1545-5017.70556
Vancouver
Papyan R, Ghamloush F, Sidhom I, Belgaumi A, Nasr R, Sultan I, et al. Navigating the Planning and Initiation of a First Prospective Clinical Trial Through a Regional Pediatric Oncology Consortium Within the Middle East, Africa, and Asia—A Roadmap. Pediatric Blood & Cancer. 2026;73(10). doi:10.1002/1545-5017.70556
BibTeX
@article{Papyan2026,
author = {Papyan, Ruzanna and Ghamloush, Farah and Sidhom, Iman and Belgaumi, Asim and Nasr, Rihab and Sultan, Iyad and Tamamyan, Gevorg and Radhakrishnan, Venkatraman and Rodriguez-Galindo, Carlos and Jeha, Sima and Santana, Victor M and Saab, Raya},
title = {Navigating the Planning and Initiation of a First Prospective Clinical Trial Through a Regional Pediatric Oncology Consortium Within the Middle East, Africa, and Asia—A Roadmap},
journal = {Pediatric Blood & Cancer},
year = {2026},
volume = {73},
number = {10},
doi = {10.1002/1545-5017.70556}
}
EUVIMED